https://scholars.lib.ntu.edu.tw/handle/123456789/567699
標題: | Response to Stephane Renaud et al. | 作者: | WEN-CHI YANG JIN-YUAN SHIH CHAO-CHI HO Feng-Ming Hsu |
公開日期: | 2018 | 出版社: | Elsevier Ireland Ltd | 卷: | 129 | 期: | 1 | 起(迄)頁: | 188-189 | 來源出版物: | Radiotherapy and Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85039043484&doi=10.1016%2fj.radonc.2017.12.001&partnerID=40&md5=3651238b92d84182549663f737252726 https://scholars.lib.ntu.edu.tw/handle/123456789/567699 |
ISSN: | 0167-8140 | DOI: | 10.1016/j.radonc.2017.12.001 | SDG/關鍵字: | B Raf kinase; crizotinib; dabrafenib; epidermal growth factor receptor; epidermal growth factor receptor 2; brain metastasis; cancer radiotherapy; cancer survival; clinical outcome; Editorial; gene mutation; gene rearrangement; human; molecularly targeted therapy; oncogene; oncogene K ras; overall survival; priority journal; progression free survival; radiosensitivity; small cell lung cancer; stereotactic radiosurgery; treatment response |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。